Robert Kronstrand

Adjungerad professor

Publikationer

2023

Matilda Backberg, Svante Vikingsson, Joakim Strandberg, Sara Wall, Anna Åstrand, Hanna Karlsson, Mattias Persson, Robert Kronstrand, Henrik Green (2023) Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances-A Swedish strategy to protect public health from harm Forensic Science International, Vol. 348, Artikel 111691 Vidare till DOI
Shimpei Watanabe, Steven Baginski, Takahiro Iwai, Ritsuko Matsushita, Masahisa Takatsu, Toshio Nakanishi, Karin Lindbom, Craig Mckenzie, Svante Vikingsson, Robert Kronstrand, Henrik Gréen, Yasuo Seto (2023) Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID Journal of Analytical Toxicology, Vol. 47, s. 455-463 Vidare till DOI
Robert Kronstrand, Markus Roman, Anna Johansson, Xiongyu Wu, Henrik Gréen, Michael T. Truver (2023) Rilmazafone: A Designer Benzodiazepine Pro-Drug Involved in Fatal Intoxications Journal of Analytical Toxicology, Vol. 47, s. 640-643 Vidare till DOI
Emily Elenstal, Henrik Gréen, Robert Kronstrand, Albert Elmsjo (2023) Intralipid as a matrix additive for evaluating hyperlipidemic postmortem blood Journal of Analytical Toxicology, Vol. 47, s. 529-534 Vidare till DOI
Tobias Rautio, Daan Vangerven, Johan Dahlén, Shimpei Watanabe, Robert Kronstrand, Svante Vikingsson, Peter Konradsson, Xiongyu Wu, Henrik Gréen (2023) In vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3-fluoro-methoxyacetylfentanyl, and 3-phenylpropanoylfentanyl using LC-QTOF-HRMS together with synthesized references Drug Testing and Analysis, Vol. 15, s. 711-729 Vidare till DOI

Nyheter